Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results
Titel:
Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results
Auteur:
Coates, Laura C. Mease, Philip Kronbergs, Andris Helt, Cameron Sandoval, David Park, So Young Combe, Bernard Nash, Peter Deodhar, Atul